InvestorsHub Logo
Followers 60
Posts 11497
Boards Moderated 0
Alias Born 07/16/2006

Re: DewDiligence post# 16751

Saturday, 02/18/2017 1:10:32 PM

Saturday, February 18, 2017 1:10:32 PM

Post# of 20689

It probably is a former Hospira facility, but I don't see why that affects the timing to any material degree. Please clarify.



Dew,

We're only guessing at this point of what the problem is because we lack any of the real statements from the FDA.

If this is a Hospira facility, the odds that the problem could be major (system wide) would be much higher than if it were in an Pfizer (stateside) facility.

Hospira has always operated on a shoestring budget compared to the likes of Pfizer. Many years ago they settled many problems with the FDA, yet a year later the FDA inspected them and found none of the solutions or promises were instituted. They've had a target on their back since. Last year, a week after announcing a $200 mil fix up for a Hospira plant in Colorado Pfizer decided to close it instead.

Let's remember, that if Momenta truely stated that PFE received a FDA Letter, the Letter (deficiency notice) is normally the 3rd piece of contact that something has not been resolved. So this is nothing new, just that it's escalating.